Incidence, Implications, and Management of Sense-B-Noise Failure in Subcutaneous Cardioverter-Defibrillator Patients: insights from a large Multicenter Registry.
Jonas WörmannMarc StrikStjepan JurisicKara StoutMohamed ElRefaiNina FluschnikBeat SchaerAntonius M W van StipdonkNeil T SrinivasanSylvain PlouxAlexander BreitensteinJordana KronPaul R RobertsTobias ToennisDominik K LinzRajdip DulaiJulia Hermes-LauferJayanthi N KoneruÖmer ErkünerSebastian DittrichJan-Hendrik van den BruckJan-Hendrik SchipperArian SultanKerstin Daniela RosenbergerDaniel StevenJakob LükerPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2024)
This multicenter analysis' findings shed light on a rare but clinically highly significant adverse event in S-ICD therapy. To our knowledge we provide the first systematic multicenter analysis investigating the incidence of sense-B-noise. Due to being difficult to diagnose and limited options for resolution, management of sense-B-noise is challenging. Complete system exchange may be the only option in some patients. Educating healthcare providers involved in S-ICD patient care is crucial for ensuring accurate diagnosis and effective management of sense-B-noise issues.
Keyphrases
- healthcare
- end stage renal disease
- air pollution
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- risk factors
- cross sectional
- peritoneal dialysis
- stem cells
- emergency department
- high resolution
- patient reported outcomes
- mass spectrometry
- double blind
- bone marrow
- atrial fibrillation
- single molecule
- drug induced